A New Era Dawns in Cancer Treatment: Members of the Media Are Invited To Attend Decision Resources' Analyst Call Regarding The U.S. Approval of Provenge for Prostate Cancer
Advertisement
Provenge's Approval, Which Had Been Forecasted By Decision Resources Nearly a Decade Ago Despite Skepticism, Marks a Crucial Turning Point in the Potential of Therapeutic Vaccines in Oncology
